Article
Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.
Frontiers in endocrinology - 1 Jan 2021
van Geest Ferdy S, Gunhanlar Nilhan, Groeneweg Stefan, Visser W Edward
Abstract excerpt
Genetic defects in the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) result in MCT8 deficiency. This disorder is characterized by a combination of severe intellectual and motor disability, caused by decreased cerebral thyroid hormone signalling, and a chronic thyrotoxic state in peripheral tissues, caused by exposure to elevated serum T3 concentrations. In particular, MCT8 plays a crucial role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
